Pfizer, Biotech, Cancer treatment, Healthcare, Health, ARRY

Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer (ARRY)

By

Matthew Horwood/Getty Images Pfizer agreed to purchase Array BioPharma for $11 billion.  Array Biopharma specializes in the development and commercialization of drugs to treat cancer and other high burden diseases.  There have been several large healthcare acquisitions in 2019 focused on drugs to treat cancer.  Array BioPharma rose more than 50% before the opening bell […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.